CVR number 37193984
Industry 32.5000 Manufacture of medical and dental instruments and supplies

Nordic LCMS Service ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  5.0% 5.1% 4.2% 8.7% 8.6%  
Credit score (0-100)  45 43 47 27 27  
Credit rating  BBB BBB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  999 1,057 1,029 893 774  
EBITDA  313 256 235 194 146  
EBIT  313 256 235 194 146  
Pre-tax profit (PTP)  308.0 285.0 237.0 194.0 145.2  
Net earnings  240.0 222.0 185.0 151.0 113.2  
Pre-tax profit without non-rec. items  308 285 237 194 145  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  304 276 261 212 175  
Interest-bearing liabilities  65.0 113 84.0 0.0 1.1  
Balance sheet total (assets)  462 560 484 320 282  
Net Debt  -310 -365 -236 -185 -213  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  999 1,057 1,029 893 774  
Gross profit growth  -4.4% 5.8% -2.6% -13.2% -13.3%  
Employees  1 2 2 2 2  
Employee growth %  0.0% 100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  462 560 484 320 282  
Balance sheet change%  -20.1% 21.2% -13.6% -33.9% -11.8%  
Added value  313.0 256.0 235.0 194.0 145.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  31.3% 24.2% 22.8% 21.7% 18.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  60.2% 56.6% 46.2% 48.5% 48.4%  
ROI %  76.2% 76.3% 65.7% 70.0% 75.1%  
ROE %  72.0% 76.6% 68.9% 63.8% 58.5%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  65.8% 49.3% 53.9% 66.3% 62.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -99.0% -142.6% -100.4% -95.4% -146.2%  
Gearing %  21.4% 40.9% 32.2% 0.0% 0.6%  
Net interest  0 0 0 0 0  
Financing costs %  6.5% 4.5% 4.1% 2.4% 102.6%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  2.9 2.0 2.2 3.0 2.6  
Current Ratio  2.9 2.0 2.2 3.0 2.6  
Cash and cash equivalent  375.0 478.0 320.0 185.0 214.0  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  201.0 140.0 261.0 212.0 174.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  313 128 118 97 73  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  313 128 118 97 73  
EBIT / employee  313 128 118 97 73  
Net earnings / employee  240 111 93 76 57